- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Wayne Burton on the Impact of Workers With Migraine on Employers
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Wayne Burton, MD, former global corporate medical director for American Express discusses the impact that workers with migraine have on employers.
Transcript:
What kind of impact do workers with migraine have on employers? Do employers see a loss of revenue or productivity? How can this be mitigated?
Migraine is extremely important to employers because if you think about migraine headaches, they effect people basically between age 25 and 55—prime age group for workers. Eighteen percent are women, about 6% are men, and it has significant impacts on on-the-job productivity, or so-called presenteeism, as well as direct costs, [like] medical costs [and] pharmacy costs. So, it’s an exceedingly important medical condition for employers.
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
A coverage with evidence development (CED) study demonstrated significant and clinically meaningful benefits in patients with migraine treated with remote electrical neuromodulation (REN). Health plans should support clinicians’ REN prescriptions by ensuring adequate coverage.
Read More
